We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Anacor will receive $40 million as an upfront payment from an exclusive agreement with Schering-Plough to develop and sell a topical antifungal therapy, the company said.
The FDA has followed a joint advisory committee's recommendations in removing two of three approved indications for Ketek and adding a black box warning to the antibiotic's labeling.
Manufacturing methods used by Pfizer to produce its top-selling hypertension treatment drug Norvasc do not infringe on patents held by Synthon, a federal district court has ruled.
Government healthcare programs must require more price transparency and better reporting to stop pharmaceutical companies from overcharging them for medications, according to experts and activists testifying at a House committee hearing last week.
The FDA has signed a memorandum of understanding (MOU) with the Department of Veterans Affairs (VA) in which the two bodies will share information and expertise related to the review and use of devices, drugs and biologics.
Despite a 28 percent increase in profits and an 11 percent rise in sales, AstraZeneca will cut approximately 3,000 jobs to help with anticipated losses from generic competition, the company announced.
A newly published survey suggests that orthopedists want to see a shorter FDA drug approval process and a return to the market of Vioxx, despite the agency's concerns with the drug.